{"id":2162,"date":"2020-09-21T16:16:57","date_gmt":"2020-09-21T14:16:57","guid":{"rendered":"https:\/\/www.arbios.org\/?p=2162"},"modified":"2020-09-21T16:17:23","modified_gmt":"2020-09-21T14:17:23","slug":"aptys-pharmaceuticals-receives-e750000-from-bpi-france-for-its-metapain-project","status":"publish","type":"post","link":"https:\/\/www.arbios.org\/en\/aptys-pharmaceuticals-receives-e750000-from-bpi-france-for-its-metapain-project\/","title":{"rendered":"Aptys Pharmaceuticals receives \u20ac750,000 from BPI France for its Metapain project."},"content":{"rendered":"<p>In September 2020, Aptys Pharmaceuticals received a \u20ac750,000 repayable grant from BPIFRANCE FINANCEMENT to support the development of its pain medicine.<\/p>\n<p>Named Metapain, the project is the result of a collaboration initiated in January 2017 between APTYS Pharmaceuticals and CDMO UNITHER Pharmaceuticals, world leader in the production of sterile single-dose drugs.<\/p>\n<p>The Metapain project aims to market a tablet based on the combination of two non-opioid analgesic molecules.\u00a0This product represents a new alternative for the treatment of moderate to severe pain.\u00a0It aims to fill the gap left by the withdrawal of Di-Antalvic in the arsenal of pain treatment.\u00a0After receiving favourable scientific advice from the EMA on their programme, the partners are preparing an international phase 3 study, which should start at the end of the year.<\/p>\n<p><span style=\"color: #008000;\"><strong>APTYS PHARMACEUTICALS<\/strong><\/span><br \/>\n<span style=\"color: #008000;\"><strong>Biop\u00f4le Clermont-Limagne<\/strong><\/span><br \/>\nPhone: +33\u00a0473\u00a0670 670<br \/>\nContact: Fran\u00e7ois Boutignon |\u00a0<a href=\"mailto:contact@aptys-pharmaceuticals.com\">contact@aptys-pharmaceuticals.com<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>In September 2020, Aptys Pharmaceuticals received a \u20ac750,000 repayable grant from BPIFRANCE FINANCEMENT to support the development of its pain medicine. Named Metapain, the project is the result of a collaboration initiated in January 2017 between APTYS Pharmaceuticals and CDMO UNITHER Pharmaceuticals, world leader in the production of sterile single-dose drugs. The Metapain project aims [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":2158,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-2162","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Aptys Pharmaceuticals receives \u20ac750,000 from BPI France for its Metapain project. - Arbios<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.arbios.org\/en\/aptys-pharmaceuticals-receives-e750000-from-bpi-france-for-its-metapain-project\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Aptys Pharmaceuticals receives \u20ac750,000 from BPI France for its Metapain project. - Arbios\" \/>\n<meta property=\"og:description\" content=\"In September 2020, Aptys Pharmaceuticals received a \u20ac750,000 repayable grant from BPIFRANCE FINANCEMENT to support the development of its pain medicine. Named Metapain, the project is the result of a collaboration initiated in January 2017 between APTYS Pharmaceuticals and CDMO UNITHER Pharmaceuticals, world leader in the production of sterile single-dose drugs. The Metapain project aims [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.arbios.org\/en\/aptys-pharmaceuticals-receives-e750000-from-bpi-france-for-its-metapain-project\/\" \/>\n<meta property=\"og:site_name\" content=\"Arbios\" \/>\n<meta property=\"article:published_time\" content=\"2020-09-21T14:16:57+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2020-09-21T14:17:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.arbios.org\/wp-content\/uploads\/2020\/09\/111220PHARMA_8960-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1000\" \/>\n\t<meta property=\"og:image:height\" content=\"790\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"arbios\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"arbios\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.arbios.org\/en\/aptys-pharmaceuticals-receives-e750000-from-bpi-france-for-its-metapain-project\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.arbios.org\/en\/aptys-pharmaceuticals-receives-e750000-from-bpi-france-for-its-metapain-project\/\"},\"author\":{\"name\":\"arbios\",\"@id\":\"https:\/\/www.arbios.org\/#\/schema\/person\/d4764a06f595d90cc731f0cbaa14ba7b\"},\"headline\":\"Aptys Pharmaceuticals receives \u20ac750,000 from BPI France for its Metapain project.\",\"datePublished\":\"2020-09-21T14:16:57+00:00\",\"dateModified\":\"2020-09-21T14:17:23+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.arbios.org\/en\/aptys-pharmaceuticals-receives-e750000-from-bpi-france-for-its-metapain-project\/\"},\"wordCount\":148,\"image\":{\"@id\":\"https:\/\/www.arbios.org\/en\/aptys-pharmaceuticals-receives-e750000-from-bpi-france-for-its-metapain-project\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.arbios.org\/wp-content\/uploads\/2020\/09\/111220PHARMA_8960-1.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.arbios.org\/en\/aptys-pharmaceuticals-receives-e750000-from-bpi-france-for-its-metapain-project\/\",\"url\":\"https:\/\/www.arbios.org\/en\/aptys-pharmaceuticals-receives-e750000-from-bpi-france-for-its-metapain-project\/\",\"name\":\"Aptys Pharmaceuticals receives \u20ac750,000 from BPI France for its Metapain project. - Arbios\",\"isPartOf\":{\"@id\":\"https:\/\/www.arbios.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.arbios.org\/en\/aptys-pharmaceuticals-receives-e750000-from-bpi-france-for-its-metapain-project\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.arbios.org\/en\/aptys-pharmaceuticals-receives-e750000-from-bpi-france-for-its-metapain-project\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.arbios.org\/wp-content\/uploads\/2020\/09\/111220PHARMA_8960-1.jpg\",\"datePublished\":\"2020-09-21T14:16:57+00:00\",\"dateModified\":\"2020-09-21T14:17:23+00:00\",\"author\":{\"@id\":\"https:\/\/www.arbios.org\/#\/schema\/person\/d4764a06f595d90cc731f0cbaa14ba7b\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.arbios.org\/en\/aptys-pharmaceuticals-receives-e750000-from-bpi-france-for-its-metapain-project\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.arbios.org\/en\/aptys-pharmaceuticals-receives-e750000-from-bpi-france-for-its-metapain-project\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.arbios.org\/en\/aptys-pharmaceuticals-receives-e750000-from-bpi-france-for-its-metapain-project\/#primaryimage\",\"url\":\"https:\/\/www.arbios.org\/wp-content\/uploads\/2020\/09\/111220PHARMA_8960-1.jpg\",\"contentUrl\":\"https:\/\/www.arbios.org\/wp-content\/uploads\/2020\/09\/111220PHARMA_8960-1.jpg\",\"width\":1000,\"height\":790,\"caption\":\"20\/12\/11 - SAINT BEAUZIRE - PUY DE DOME - FRANCE - APTYS PHARMA. Laboratoire de recherche en produits pharmacologiques - Photo Jerome CHABANNE\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.arbios.org\/en\/aptys-pharmaceuticals-receives-e750000-from-bpi-france-for-its-metapain-project\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/www.arbios.org\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Aptys Pharmaceuticals receives \u20ac750,000 from BPI France for its Metapain project.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.arbios.org\/#website\",\"url\":\"https:\/\/www.arbios.org\/\",\"name\":\"Arbios\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.arbios.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.arbios.org\/#\/schema\/person\/d4764a06f595d90cc731f0cbaa14ba7b\",\"name\":\"arbios\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.arbios.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/edc889faeb33c603c9491f1e7966135090d534f607758d58358d3f371a6c8583?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/edc889faeb33c603c9491f1e7966135090d534f607758d58358d3f371a6c8583?s=96&d=mm&r=g\",\"caption\":\"arbios\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Aptys Pharmaceuticals receives \u20ac750,000 from BPI France for its Metapain project. - Arbios","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.arbios.org\/en\/aptys-pharmaceuticals-receives-e750000-from-bpi-france-for-its-metapain-project\/","og_locale":"en_US","og_type":"article","og_title":"Aptys Pharmaceuticals receives \u20ac750,000 from BPI France for its Metapain project. - Arbios","og_description":"In September 2020, Aptys Pharmaceuticals received a \u20ac750,000 repayable grant from BPIFRANCE FINANCEMENT to support the development of its pain medicine. Named Metapain, the project is the result of a collaboration initiated in January 2017 between APTYS Pharmaceuticals and CDMO UNITHER Pharmaceuticals, world leader in the production of sterile single-dose drugs. The Metapain project aims [&hellip;]","og_url":"https:\/\/www.arbios.org\/en\/aptys-pharmaceuticals-receives-e750000-from-bpi-france-for-its-metapain-project\/","og_site_name":"Arbios","article_published_time":"2020-09-21T14:16:57+00:00","article_modified_time":"2020-09-21T14:17:23+00:00","og_image":[{"width":1000,"height":790,"url":"https:\/\/www.arbios.org\/wp-content\/uploads\/2020\/09\/111220PHARMA_8960-1.jpg","type":"image\/jpeg"}],"author":"arbios","twitter_card":"summary_large_image","twitter_misc":{"Written by":"arbios","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.arbios.org\/en\/aptys-pharmaceuticals-receives-e750000-from-bpi-france-for-its-metapain-project\/#article","isPartOf":{"@id":"https:\/\/www.arbios.org\/en\/aptys-pharmaceuticals-receives-e750000-from-bpi-france-for-its-metapain-project\/"},"author":{"name":"arbios","@id":"https:\/\/www.arbios.org\/#\/schema\/person\/d4764a06f595d90cc731f0cbaa14ba7b"},"headline":"Aptys Pharmaceuticals receives \u20ac750,000 from BPI France for its Metapain project.","datePublished":"2020-09-21T14:16:57+00:00","dateModified":"2020-09-21T14:17:23+00:00","mainEntityOfPage":{"@id":"https:\/\/www.arbios.org\/en\/aptys-pharmaceuticals-receives-e750000-from-bpi-france-for-its-metapain-project\/"},"wordCount":148,"image":{"@id":"https:\/\/www.arbios.org\/en\/aptys-pharmaceuticals-receives-e750000-from-bpi-france-for-its-metapain-project\/#primaryimage"},"thumbnailUrl":"https:\/\/www.arbios.org\/wp-content\/uploads\/2020\/09\/111220PHARMA_8960-1.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.arbios.org\/en\/aptys-pharmaceuticals-receives-e750000-from-bpi-france-for-its-metapain-project\/","url":"https:\/\/www.arbios.org\/en\/aptys-pharmaceuticals-receives-e750000-from-bpi-france-for-its-metapain-project\/","name":"Aptys Pharmaceuticals receives \u20ac750,000 from BPI France for its Metapain project. - Arbios","isPartOf":{"@id":"https:\/\/www.arbios.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.arbios.org\/en\/aptys-pharmaceuticals-receives-e750000-from-bpi-france-for-its-metapain-project\/#primaryimage"},"image":{"@id":"https:\/\/www.arbios.org\/en\/aptys-pharmaceuticals-receives-e750000-from-bpi-france-for-its-metapain-project\/#primaryimage"},"thumbnailUrl":"https:\/\/www.arbios.org\/wp-content\/uploads\/2020\/09\/111220PHARMA_8960-1.jpg","datePublished":"2020-09-21T14:16:57+00:00","dateModified":"2020-09-21T14:17:23+00:00","author":{"@id":"https:\/\/www.arbios.org\/#\/schema\/person\/d4764a06f595d90cc731f0cbaa14ba7b"},"breadcrumb":{"@id":"https:\/\/www.arbios.org\/en\/aptys-pharmaceuticals-receives-e750000-from-bpi-france-for-its-metapain-project\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.arbios.org\/en\/aptys-pharmaceuticals-receives-e750000-from-bpi-france-for-its-metapain-project\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.arbios.org\/en\/aptys-pharmaceuticals-receives-e750000-from-bpi-france-for-its-metapain-project\/#primaryimage","url":"https:\/\/www.arbios.org\/wp-content\/uploads\/2020\/09\/111220PHARMA_8960-1.jpg","contentUrl":"https:\/\/www.arbios.org\/wp-content\/uploads\/2020\/09\/111220PHARMA_8960-1.jpg","width":1000,"height":790,"caption":"20\/12\/11 - SAINT BEAUZIRE - PUY DE DOME - FRANCE - APTYS PHARMA. Laboratoire de recherche en produits pharmacologiques - Photo Jerome CHABANNE"},{"@type":"BreadcrumbList","@id":"https:\/\/www.arbios.org\/en\/aptys-pharmaceuticals-receives-e750000-from-bpi-france-for-its-metapain-project\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.arbios.org\/en\/"},{"@type":"ListItem","position":2,"name":"Aptys Pharmaceuticals receives \u20ac750,000 from BPI France for its Metapain project."}]},{"@type":"WebSite","@id":"https:\/\/www.arbios.org\/#website","url":"https:\/\/www.arbios.org\/","name":"Arbios","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.arbios.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.arbios.org\/#\/schema\/person\/d4764a06f595d90cc731f0cbaa14ba7b","name":"arbios","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.arbios.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/edc889faeb33c603c9491f1e7966135090d534f607758d58358d3f371a6c8583?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/edc889faeb33c603c9491f1e7966135090d534f607758d58358d3f371a6c8583?s=96&d=mm&r=g","caption":"arbios"}}]}},"_links":{"self":[{"href":"https:\/\/www.arbios.org\/en\/wp-json\/wp\/v2\/posts\/2162","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.arbios.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.arbios.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.arbios.org\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.arbios.org\/en\/wp-json\/wp\/v2\/comments?post=2162"}],"version-history":[{"count":1,"href":"https:\/\/www.arbios.org\/en\/wp-json\/wp\/v2\/posts\/2162\/revisions"}],"predecessor-version":[{"id":2163,"href":"https:\/\/www.arbios.org\/en\/wp-json\/wp\/v2\/posts\/2162\/revisions\/2163"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.arbios.org\/en\/wp-json\/wp\/v2\/media\/2158"}],"wp:attachment":[{"href":"https:\/\/www.arbios.org\/en\/wp-json\/wp\/v2\/media?parent=2162"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}